Your browser doesn't support javascript.
loading
Genotype And Abo Blood Group Association With Prevalence Of Malaria Among Patients In University Of Nigeria Medical Center: A Cross-Sectional Evaluation
Int J Pharm Pharm Sci ; 2019 Jun; 11(6): 28-32
Article | IMSEAR | ID: sea-205906
ABSTRACT

Objective:

The aim of this study was to evaluate the prevalence of malaria and its relationship with the ABO blood group and genotype at the University of Nigeria Medical Centre.

Methods:

The study had a prospective cross-sectional design in which malaria status and blood groups and genotype were determined. All collected data were analysed using Statistical product and services Solution (V.21). Frequencies and percentages were used to describe the data while Chi-square and Pearson correlation were used to determine associations between malaria prevalence and patients’ demographic and clinical characteristics. Statistical significance was considered for p<0.05.

Results:

Three hundred and twenty-three (323) patients were tested for malaria, 245(75.9%) of whom tested positive. The prevalence was highest for patient’s aged 19-25 y (28.5%). The difference was statistically significant for age χ2 (5) = 33.60, p = 0.0005. There were more blood group O (57.6%) among the patients, while AA genotype was the majority (72.4%). Those with blood group O had the highest prevalence of malaria (33.7%) and it was statistically significant (χ2 (3) = 72.10, p = 0.0005)). Correlation showed that the association between blood group and malaria prevalence was moderate (R = 0.457). The AA genotype had more incidence of malaria (54.5%), but the difference was not statistically significant.

Conclusion:

The prevalence of malaria was high among the patients surveyed. Its association with the patientsABO blood group was established to be statistically significant, with blood group O having the highest incidence. Although AA genotype was observed to have the highest cases of malaria, the relationship was found not to be significant.

Full text: Available Index: IMSEAR (South-East Asia) Type of study: Prevalence study / Risk factors Journal: Int J Pharm Pharm Sci Year: 2019 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: IMSEAR (South-East Asia) Type of study: Prevalence study / Risk factors Journal: Int J Pharm Pharm Sci Year: 2019 Type: Article